Results 201 to 210 of about 166,918 (340)

Higher Composite Social Determinants of Health Scores Are Associated With Worse Survival in Patients With Small Bowel Neuroendocrine Tumors

open access: yesJournal of Surgical Oncology, EarlyView.
ABSTRACT Background Patients with early‐stage well‐differentiated small bowel neuroendocrine tumors (sbNETs) experience favorable prognosis with timely diagnosis and treatment. However, the impact of social determinants of health (SDH) and care at Minority‐Serving Hospitals (MSHs) on outcomes remains understudied.
Ahmed Alnajar   +3 more
wiley   +1 more source

Management of type I gastric-neuroendocrine tumors: the less the better? [PDF]

open access: yesFront Endocrinol (Lausanne)
Rossi RE   +10 more
europepmc   +1 more source

Neuroendocrine tumors

open access: yesIndian Journal of Medical Research, 2017
Shrikhande, S.V., Sivasanker, M.
openaire   +1 more source

Harnessing Gut Microbiome–Brain–Liver Crosstalk: Novel Therapeutic Strategies for Metabolic Dysfunction‐Associated Steatotic Liver Disease

open access: yesMedicine Bulletin, EarlyView.
This review reveals the complex mechanisms by which the brain–gut–liver axis (particularly the gut microbiota and its metabolites) drives MASLD, highlighting the therapeutic value of using phages to target and eliminate pathogenic bacteria and their metabolic products.
Xingtao Zhao   +7 more
wiley   +1 more source

DNA methyltransferase 1 correlates with immune modulation in pancreatic neuroendocrine tumors. [PDF]

open access: yesSci Rep
Saleh Z   +10 more
europepmc   +1 more source

Tumor Organoids: Breakthroughs in Clinical Decision Making, Drug Development, and Translational Advances Beyond Conventional Models

open access: yesMed Research, EarlyView.
ABSTRACT Tumor organoid models are revolutionizing cancer research by bridging the translational gap between conventional two‐dimensional cell cultures and animal models. This Editorial thoroughly explores the fundamental innovations of patient‐derived organoid technology.
Yimao Wu   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy